|
1) Merskey H, et al. Classification of chronic pain, 2nd ed. Seatle: IASP Press; 1994. p.207
|
|
|
|
|
2) Loeser JD, Treede RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain. 2008; 137: 473-7
|
|
|
|
|
3) Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008; 136: 380-7
|
|
|
|
|
|
4) Melzak R, Katz J. Pain assessment in adult patients. In: Wall PD, Melzak R, editors. Textbook of Pain. Edinburg: Churchill Livingstone; 2008. p.291-316
|
|
|
|
|
|
5) Gilron I, Watson CP, Cahill CM, et al. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006; 175: 265-75
|
|
|
|
|
|
6) 細川豊史. 定義と臨床的特徴. In: 小川節郎, 編. 神経障害性疼痛治療ガイドブック. 東京: 南山堂; 2010. p.2-4
|
|
|
|
|
|
7) Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008; 70: 1630-5
|
|
|
|
|
|
8) 細川豊史. 分類. In: 小川節郎, 編. 神経障害性疼痛治療ガイドブック. 東京: 南山堂; 2010. p.5-9
|
|
|
|
|
|
9) 小川節郎. 日本人慢性疼痛患者における神経障害性疼痛スクリーニングツール質問表の開発. ペインクリニック. 2010; 31: 1187-94
|
|
|
|
|
|
10) 住谷昌彦, 齋藤洋一, 信太賢治, 他. 第3治療 3-6項. In: 小川節郎, 編. 神経障害性疼痛治療ガイドブック. 東京: 南山堂; 2010. p.86-114
|
|
|
|
|
|
11) Dworking RH, OʼConnor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain. 2007; 132: 237-51
|
|
|
|
|
|
12) Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006; 13: 1153-69
|
|
|
|
|
|
13) 神経障害性疼痛に対する薬物療法ガイドライン. 日本ペインクリニック学会誌. 投稿中
|
|
|
|
|
|
14) Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 1997; 13: 327-31
|
|
|
|
|
|
15) Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007; 88: 1547-60
|
|
|
|
|
|
16) Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 2003; 60: 1284-9
|
|
|
|
|
|
17) Watson CPN, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998; 51: 1166-71
|
|
|
|
|
|
18) Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004; 109: 26-35
|
|
|
|
|
|
19) Dworkin RH, Corbin AE, Young JP, Jr. et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003: 60: 1274-83
|
|
|
|
|
|
20) Stacey BR, Barrett JA, Whalen E, et al. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain. 2008; 9: 1006-17
|
|
|
|
|
|
21) Arezzo JC, Rosenstock J, Lamoreaux L, et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008; 8: 33
|
|
|
|
|
|
22) Rosenstock J, Tuchman M, Lamoreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004; 110: 628-38
|
|
|
|
|
|
23) Tolle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. Eur J Pain. 2008; 12: 203-13
|
|
|
|
|
|
24) Freeman R, Durso-DeCruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care. 2008; 31: 1448-54
|
|
|
|
|
|
25) Saldaña MT, Navarro A, Pérez C, et al. Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int. 2010; 30: 1005-15
|
|
|
|
|
|
26) 山村秀夫, 檀健二郎, 若杉文吉, 他. ノイロトロピン錠の帯状疱疹後神経痛に対する効果 プラセボ錠を対照薬とした多施設二重盲検試験. 医学のあゆみ. 1988; 147: 651-64
|
|
|
|
|
27) 祖父江逸郎, 花籠良一, 松本昭久, 他. SMON (subacute myelo-optico-neuropathy) 後遺症に対するノイロトロピンの臨床評価 多施設二重盲検交差比較試験. 医学のあゆみ. 1987; 143: 233-52
|
|
|
|
|
|
28) Goldstein DJ, Lu Y, Detke MJ et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005; 116: 109-18
|
|
|
|
|
|
29) Wernicke JF, Pritchett YL, DʼSouza DN et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006; 67: 1411-20
|
|
|
|
|
|
30) Nishizawa Y, Yoshioka F, et al. Improving and Protecting Effect and Safety of Mexiletine Hydrochloride or Mianserin Hydrochloride on Painful Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus for 2 years in Prospective Randomized Well-controlled Comparative Study. 慢性疼痛. 2005; 24: 137-48
|
|
|
|
|
|
31) 宮崎東洋, 花岡一雄, 並木昭義, 他. デュロテップ®MTパッチの非癌性慢性疼痛患者を対象とした臨床試験I: 4週および長期(52週)貼付. 新薬と臨床. 2010; 59: 157-80
|
|
|
|
|
|
32) Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: A radomized trial in post-herpetic neuralgia. Neurology 1998; 50: 1837-41
|
|
|
|
|
|
33) Watson CPN, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003; 105: 71-8
|
|
|
|
|
|
34) Agarwal S, Tella PK et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology. 2008; 109: 289-96
|
|
|
|
|
|
35) Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005; 352: 1324-34
|
|
|
|
|
|
36) Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003; 348: 1223-32
|
|
|
|
|
|
37) Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007; 11: 490-518
|
|
|
|
|
|
38) Watson CPN, Watt-Watson JH, Chipman ML. Chronic non-cancer pain and the long term utility of opioids. Pain Res Manage. 2004; 9: 19-24
|
|
|
|
|
|
39) Arbaiza D, Vidal O. Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study. Clin Drug Investig. 2007; 27: 75-83
|
|
|
|
|
|
40) Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003; 104: 323-31
|
|
|
|
|